Rexulti 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FY8TC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,746
Award facts
- Contract value 100% obligated
- $13,745.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,745.79 to AmerSourceBergen Drug Corp for 30 tablets of Rexulti 1 mg on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price, non-set-aside contract with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerSourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally.
Rexulti (brexpiprazole) is an antipsychotic medication used in treating mental health conditions including schizophrenia and major depressive disorder. AmerSourceBergen Drug Corp, as a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills such delivery orders covering a comprehensive range of therapeutic domains through its expansive IDC with DLA. The contract reflects the company's established capability to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across the defense medical supply chain through competitive, firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DR26FY8TC?
SPE2DR26FY8TC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FY8TC worth?
The government has obligated $13,746 on SPE2DR26FY8TC.
Is contract SPE2DR26FY8TC an order under another contract?
Yes. SPE2DR26FY8TC is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8TC competed?
The extent of competition for SPE2DR26FY8TC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award